The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
Werling
Krist
K
McGuire Woods, LLP.
Abraham
Sarah
S
Strelec
Jessica
J
D002608:Charities; D003132:Commerce / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D033161:Government Regulation; D006268:Health Facilities / Q000191:economics; D006801:Humans; D008484:Medicaid / Q000331:legislation & jurisprudence; D017057:Medically Uninsured; D010045:Outpatients; D004364:Pharmaceutical Preparations / Q000191:economics; D014481:United States; D014488:United States Health Resources and Services Administration
D004364:Pharmaceutical Preparations